Sante Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Reimagine Care partners with cancer providers and health systems to deliver virtual oncology care combining AI-powered support, clinical expertise, and digital monitoring to manage symptoms, reduce emergency visits, and improve patient outcomes outside the clinic setting.
AI & Machine LearningDigital HealthHealthtechNashville, US
Dan Nardi(Mr. Nardi is the CEO and a director of the Issuer)Keith Figlioli(Director)Feby Abraham(Director)Chris Stenzel(Director)
BoardDouglas French(Director)Harlan Levine(Director)in
Co-investorsCU Healthcare Innovation FundMartin VenturesMcKesson VenturesOncology VenturesLRVHealth
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalRoute 66 VenturesService Provider Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.